OTC · Technology

Bioforce Nanosciences Holdings, Inc. (BFNH)

It posted a net loss of $97.4K. At June 30, 2026 it held $307 in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 10, 2026.

Watch BFNH in 60 seconds

Price

$9.35

+1.74% on the day · September 25, 2026

52-week range $0.18 to $10.99

Market cap

$313.7M

What Bioforce Nanosciences Holdings, Inc. does

Bioforce Nanosciences Holdings, Inc. is registered with the SEC under industry code SIC 3826 (Laboratory Analytical Instruments). Its shares trade on OTC under the ticker BFNH.

Revenue and profit by year

Revenue

Net income

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal year	Revenue	Operating income	Net income	Diluted EPS	Free cash flow
2025	n/a	n/a	-$1.3M	-$0.04	n/a
2024	n/a	n/a	-$490.4K	-$0.02	n/a
2023	n/a	n/a	-$472K	-$0.02	n/a
2022	n/a	n/a	-$485.5K	-$0.02	n/a
2021	n/a	n/a	-$502K	-$0.02	n/a
2020	n/a	n/a	-$158.4M	-$9.72	n/a

Full financial statements: income, balance sheet and cash flow

Next report expected around November 18, 2026.

Estimated from its filing rhythm: 52 weeks after its report of November 19, 2025. Not a date the company has announced. See the report calendar

Latest SEC filings

What Bioforce Nanosciences Holdings, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

September 4, 2026
Activist stake (5% or more) SCHEDULE 13D
September 4, 2026
Unregistered share sale 8-K
August 18, 2026
Investor disclosure 8-K
August 14, 2026
Other event 8-K
August 10, 2026
Quarterly report 10-Q · period to June 30, 2026Diluted EPS $0.01 versus $0.00.
July 7, 2026
Other event 8-K
July 1, 2026
Other event 8-K
June 18, 2026
Change in control 8-K
May 19, 2026
Quarterly report 10-Q · period to March 31, 2026Diluted EPS $0.00 versus -$0.03.
May 13, 2026
Late quarterly report notice NT 10-Q

Recent insider filings (Forms 3, 4 and 144): 10, the latest on September 4, 2026. Insider transactions on SEC

Insider trades

What the people running Bioforce Nanosciences Holdings, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.

No insider bought or sold shares on the open market in the last 90 days. The 2 reported changes were pay in shares, option exercises, shares withheld for tax or gifts.

Bought (open market)

last 90 days

Sold

last 90 days

Date	Insider	What	Shares	Price	Value	Filing
August 31, 2026	Kaiser Richard KaiserCEO & CFO, Director	Received as pay	316,909	$0.55	$174.3K	Form 4
August 20, 2026	Kaiser Richard KaiserCEO & CFO, Director	Other change	38,462	$0.65	$25K	Form 4
April 22, 2026	Ferguson MerleDirector	Sold	26,700,000	$0.02	$400.5K	Form 4
April 20, 2026	Kaiser Richard KaiserCEO & CFO, Director	Gave as a gift	4,132,000	$0.00	$4.1K	Form 4
April 20, 2026	Ferguson MerleDirector	Gave as a gift	20,580,000	$0.01	$144.1K	Form 4
April 20, 2026	Ferguson MerleDirector	Gave as a gift	4,132,000	$0.00	$4.1K	Form 4

All insider filings on SEC.gov · Where insiders are buying across the market

Who owns BFNH

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

Holder	Of class	Shares	Filed
Nexus Capital Investments, Inc.13D, may seek influence	79.6%	26,700,000	September 4, 2026

Largest institutional holders

No Form 13F positions imported for this company yet.

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

1 insiders reported holding 1,234,447 shares in total, about $11.5M at the last price.

Holder	Shares	As of
Kaiser Richard KaiserCEO & CFO, Director	1,234,447	August 31, 2026

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about BFNH

What does Bioforce Nanosciences Holdings, Inc. do?

Bioforce Nanosciences Holdings, Inc. is registered with the SEC under industry code SIC 3826 (Laboratory Analytical Instruments). Its shares trade on OTC under the ticker BFNH.

Is Bioforce Nanosciences Holdings, Inc. profitable?

No. Over the twelve months to June 30, 2026 it reported a net loss of $97.4K.

When did Bioforce Nanosciences Holdings, Inc. last report?

Its most recent periodic report is the quarterly report (10-Q) filed on August 10, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the activist stake (5% or more) from September 4, 2026.

Similar companies

Agilent Technologies, Inc.

Mettler Toledo International Inc/

Compare BFNH with

Compare BFNH with any company

Follow BFNH

Get an email when Bioforce Nanosciences Holdings, Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Follow BFNH: get an email when it files

Where the numbers come from

Financial figures are the values Bioforce Nanosciences Holdings, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.